Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 375-380

  Jiang, Aigui ^a   Gao, Xiaoyan ^a   Zhang, Degeng ^a   Zhang, Lixin ^a   Lu, Huiyu ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Non small cell lung carcinoma; Prognosis; Survival; Trop 2

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SURVIVAL; TROP 2 GENE;

EID: 84879495657     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1368     Document Type: Article

References (16)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Jiang HF and Bo JJ: Trophoblastic cell surface protein 2 and tumor. J Int Oncol 39: 96-98, 2012 (In Chinese).
3. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K and MoriM: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063, 2006.
4. Fong D, Spizzo G, Gostner JM, et al: TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 21: 186-191, 2008.
5. Fong D, Moser P, Krammel C, et al: High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer99: 1290-1295, 2008.
6. Wang J, Day R, Dong Y, Weintraub SJ and Michel L: Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther 7: 280-285, 2008.
7. Kobayashi H, Minami Y, Anami Y, et al; IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions: Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma. Virchows Arch 457: 69-76, 2010.
8. Pak MG, Shin DH, Lee CH and Lee MK: Significance of EpCAM and TROP2 expression in non-small cell lung cancer. World J Surg Oncol 10: 53, 2012.
9. Groome PA, Bolejack V, Crowley JJ, et al; IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions: The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol 2: 694-705, 2007.
10. Calabrese G, Crescenzi C, Morizio E, Palka G, Guerra E and Alberti S: Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet 92: 164-165, 2001.
11. Taylor JT, Zeng XB, Pottle JE, et al: Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol14: 4984-4991, 2008.
12. Nelsen CJ, Kuriyama R, Hirsch B, et al: Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem 280: 768-776, 2005.
13. Cubas R, Zhang S, Li M, Chen C and Yao Q: Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 9: 253, 2010.
14. Zhang B, Yao YF and Zhou P: Two novel mutations identified in two Chinese gelatinous drop-like corneal dystrophy families. Mol Vis 13: 988-992, 2007.
15. Markoff A, Bogdanova N, Uhlig CE, Groppe M, Horst J and Kennerknecht I: A novel TACSTD2 gene mutation in a Turkish family with a gelatinous drop-like corneal dystrophy. Mol Vis12: 1473-1476, 2006.
16. Alavi A, Elahi E, Tehrani MH, et al: Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients. Invest Ophthalmol Vis Sci 48: 4490-4497, 2007.